The $700 million project is part of Roche’s $50 billion investment in US manufacturing, infrastructure and R&D
Anthony brings more than 25 years of pharmaceutical development and CRO experience to his expanded role
KER-065 is a novel ligand trap comprised of a modified ligand-binding domain derived from activin receptor type IIA and activin receptor type IIB
The company is bringing precision therapies for gynaecological cancers
Mangalam Drugs and Organics receives repeat export order worth $ 21, 81,040
All 2025 pre-filled syringe doses to be made in Canada, marking a domestic production milestone
Astaxanthin is a powerful antioxidant and red-orange carotenoid pigment found in various aquatic organisms
The facility will be positioned as a Centre of Excellence for tertiary care services
Vivo Bio Tech will have end-to-end responsibility for conducting the full spectrum of pre-clinical safety and regulatory studies
Subscribe To Our Newsletter & Stay Updated
